Full-Time
PLM Application Engineer
Teamcenter
ConvaTec Group
5,001-10,000 employees
Develops medical devices for chronic care
No salary listed
Remote in India
Remote
 Software Engineering |
|---|
Get referred to ConvaTec Group
Find people who can refer or advise you
- Minimum of 3–5 years of hands-on Teamcenter experience in a production environment, including application support, debugging, and development.
- Proficiency in Teamcenter core modules (BOM Management, Workflow, Classification, Change Management, Dispatcher) and Active Workspace; experience with Polarion.
- Hands-on development experience with Teamcenter ITK (C/C++ or Java), BMIDE data model configuration, workflow handler programming, and Active Workspace (AWC) client-side customization.
- Understanding of medical device regulatory requirements: FDA 21 CFR Part 11 (electronic records/signatures), ISO 13485 (QMS), EU MDR 2017/745, IEC 62304 (medical device software lifecycle), and ISO 14971 (risk management).
- Strong analytical and debugging skills with the ability to trace complex multi-tier Teamcenter issues across server logs, database queries, and client-side behavior.
- Excellent written and verbal communication skills; able to produce clear technical documentation and present solutions to non-technical stakeholders including QA, Regulatory Affairs, and senior management.
- Experience with Teamcenter deployment on on-premise or hybrid infrastructure (AWS, Azure) is a plus.
- Ability to deliver end-user training, create user guides and quick-reference materials, and provide ongoing helpdesk support in a regulated medical device environment.
- Resolve L1/L2/L3 Teamcenter incidents and service requests within SLA.
- Investigate, diagnose, and resolve Teamcenter application defects, server errors, workflow failures, and data issues, applying structured root-cause analysis and providing permanent fixes with full traceability.
- Develop custom Teamcenter solutions using ITK APIs, BMIDE data model configuration, Active Workspace client-side customization, Java or C++ extensions, and workflow handler development, all under a controlled GxP SDLC.
- Author and maintain controlled technical documents including System Design Specifications (SDS), Validation Plans, IQ/OQ/PQ protocols, SOPs, change control records, and user guides in compliance with ISO 13485 and 21 CFR Part 11 document control requirements.
- Support Computer System Validation (CSV) activities – including installation qualification, operational qualification, and performance qualification – to keep Teamcenter in a validated state aligned with EU MDR 2017/745, ISO 13485, and FDA 21 CFR Part 11.
- Manage day-to-day Teamcenter server administration: environment health monitoring, patch and upgrade planning, data model migrations.
- Participate in internal and external audits (FDA, Notified Body, ISO) as the Teamcenter SME, providing evidence of system validation, data integrity controls, and audit trail completeness.
- Manage change requests through the formal change control process, including impact assessments, regression testing, and updating validation documentation prior to deployment in the production environment.
- Deliver end-user training, create user guides and quick-reference materials, and provide ongoing helpdesk-level support to Teamcenter users across engineering, quality, and regulatory functions.
Convatec Group provides medical devices and services for chronic care. It designs, manufactures, and distributes products across wound care, ostomy care, continence care, and infusion care for patients and healthcare providers in nearly 100 countries. Its products aim to prevent infection, protect the skin, and support safer, easier patient care, while helping health systems lower overall costs. A notable example is the compact catheter for women, which combines discreet use with reliable protection. The company employs about 10,000 people and operates under a commitment to ongoing, reliable care—’forever caring’—to meet evolving patient and system needs. The goal is to improve patient outcomes and reduce the total cost of care through clinically and economically beneficial medical devices and services.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
London, United Kingdom
Founded
1978
Get referred to ConvaTec Group
Find people who can refer or advise you
Simplify's Take
What believers are saying
- ConvaNiox dressing heals diabetic foot ulcers 60% faster, strengthening its advanced wound care pipeline.
- eakin freeseal ostomy seal at 1.8mm depth addresses leakage for 90% of one million US patients.
- Excluding InnovaMatrix, 2025 organic growth reached 6.4% with infusion care leading at 12.5%.
What critics are saying
- CMS slashed InnovaMatrix pricing by 80%, causing a £72M impairment and 2% revenue headwind in 2026.
- Novo Holdings exited its 7.8% stake for £351M in Q2 2026, removing a strategic anchor investor.
- Coloplast intensifies US ostomy competition with premium seals, threatening ESENTA family and eakin freeseal growth.
What makes ConvaTec Group unique
- ConvaTec obsessively focuses on the device-tissue interface across four chronic care franchises.
- Its 30-year Hydrofiber technology sold 1.5 billion Aquacel dressings globally, proving market trust.
- The company delivers device-plus-service-plus-digital solutions under its 'forever caring' promise.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Company News
Convatec and Eakin Healthcare have launched eakin freeseal, a co-branded ostomy seal in the United States as part of Convatec's ESENTA family of accessories. The product is designed to prevent leaks and protect skin around stomas, addressing a significant need as approximately 90% of the 1 million Americans living with a stoma experience leakage. The eakin freeseal range includes two lines: eakin freeseal air, the thinnest seal on the market at 1.8mm depth, and eakin freeseal versa, which absorbs fluid without breaking down. Both products can absorb up to four times their weight in fluid whilst maintaining integrity beneath the skin barrier. The launch expands the partnership between Convatec, a global medical products company with over $2 billion in 2025 revenues, and Eakin Healthcare, a Northern Ireland-based ostomy solutions specialist.
Convatec and Eakin Healthcare have launched eakin freeseal, a co-branded ostomy seal designed to prevent leaks and protect skin around stomas, as part of Convatec's ESENTA family of accessories in the United States. The product range includes two lines: eakin freeseal air, the thinnest seal on the market at 1.8mm depth, designed for convex pouches; and eakin freeseal versa, which absorbs fluid without breaking down. The seals can absorb up to four times their weight in fluid whilst maintaining integrity beneath the skin barrier. With approximately 1 million people living with stomas in the US, about 90% experience leakage at some point. The new seals address this critical issue in one of the largest and fastest-growing product categories in ostomy care.
Convatec introduces co-branded eakin freeseal(R) ostomy seal in north america, expanding the ESENTA(TM) family of accessories. * 1 hr ago Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, and Eakin Healthcare, a specialist provider of ostomy solutions, today announced the launch of eakin freeseal(R), the thinnest ostomy seal used to help prevent leaks and protect the skin around a stoma. This new co-branded seal is part of the ESENTA(TM) family of accessories, available in the United States. Ostomy seals are designed to create a protective layer around the stoma to prevent leakage. Recurrent leakage can lead to skin breakdown and irritation, leading to longer term issues, both physically and emotionally for patients. With approximately 1 million people living with a stoma in the United States, about 90% experience leakage at some point in their journey[3]. The use of ostomy seals can reduce or eliminate leakage, leading to a better quality of life for those living with an ostomy. The eakin freeseal(R) range includes two product lines, eakin freeseal(R) air, and eakin freeseal(R) versa, providing healthcare professionals with versatile options that combine discretion, comfort and high performance. While Convatec currently addresses the patient's needs with the eakin Cohesive(R) seal, eakin freeseal(R) provides healthcare professionals with a wider range of options to meet their clinical needs. The thinner offering, eakin freeseal(R) air has a depth starting at 1.8mm, making it the thinnest seal on the market and is designed to be paired with convex pouches. eakin freeseal(R) versa is slightly thicker and designed to absorb fluid at the best rate in the market without breaking down, leading to easier removal for the end user. The thinness of this new ostomy seal, together with its composition and design, allows it to absorb up to four times its weight in fluid without breaking down underneath the skin barrier[1]. This high performance, combined with eakin(R) seals' best-in-market moldability[2], makes eakin freeseal(R) a relatable solution to any person living with a stoma immediately post-surgery. Ostomy seals and barriers designed to prevent leakage and skin irritation is one of the largest product categories in the United States and continues to grow at a consistent rate. Dan Yrigoyen, Vice President, US Ostomy Care at Convatec, said: "We are pleased to add eakin freeseal(R) to our ESENTA(TM) family of skin-friendly accessories, expanding the range of trusted options available to clinicians and patients, and supporting easier, more confident everyday care. with our forever caring promise. This marks a new chapter in the longstanding partnership between Convatec and Eakin Healthcare. Together we continue to advance ostomy care in line with our forever caring promise." This co-branded product reflects Convatec and Eakin Healthcare's ongoing commitment to patients and healthcare professionals to provide choice - working together to provide a better ostomy experience so patients can live the life they want. Integrating eakin(R) seals into the ESENTA(TM) range reinforces the importance of using a reliable ostomy seal as part of the customers skincare routine. About Eakin Healthcare Eakin Healthcare is a medical device manufacturer with headquarters based in Comber, Northern Ireland. Founded in 1973, pharmacist Tom Eakin saw a need to support individuals living with a stoma with better ostomy products to improve comfort, confidence, and quality of life. The company continues to build on its heritage of patient-focused innovation, combining clinical insight with advanced manufacturing to deliver reliable medical devices used worldwide. With a global presence and a strong focus on quality, the company works to enhance the lives of people managing complex healthcare needs. To learn more please visit http://www.eakinostomy.com About Convatec Pioneering trusted medical solutions to improve the lives Wpgxfox28 touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, Wpgxfox28 provide products and services in around 90 countries, united by a promise to be forever caring. Its solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com References: * Mc Groggan G, Haughey S and McDowell K (2018) An absorbent, enzyme-inhibiting seal reduces peristomal skin complications. Gastrointestinal Nursing 16:1 42-4. * T.G. Eakin Laboratory Testing Summary report, ostomy seals 2023 (Data on file) EA-005683-ST * Eakin Healthcare Stoma Census 2023 n=1992. Data on file.
Convatec introduces co-branded eakin freeseal(R) ostomy seal in north america, expanding the ESENTA(TM) family of accessories. * 21 hrs ago Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, and Eakin Healthcare, a specialist provider of ostomy solutions, today announced the launch of eakin freeseal(R), the thinnest ostomy seal used to help prevent leaks and protect the skin around a stoma. This new co-branded seal is part of the ESENTA(TM) family of accessories, available in the United States. Ostomy seals are designed to create a protective layer around the stoma to prevent leakage. Recurrent leakage can lead to skin breakdown and irritation, leading to longer term issues, both physically and emotionally for patients. With approximately 1 million people living with a stoma in the United States, about 90% experience leakage at some point in their journey[3]. The use of ostomy seals can reduce or eliminate leakage, leading to a better quality of life for those living with an ostomy. The eakin freeseal(R) range includes two product lines, eakin freeseal(R) air, and eakin freeseal(R) versa, providing healthcare professionals with versatile options that combine discretion, comfort and high performance. While Convatec currently addresses the patient's needs with the eakin Cohesive(R) seal, eakin freeseal(R) provides healthcare professionals with a wider range of options to meet their clinical needs. The thinner offering, eakin freeseal(R) air has a depth starting at 1.8mm, making it the thinnest seal on the market and is designed to be paired with convex pouches. eakin freeseal(R) versa is slightly thicker and designed to absorb fluid at the best rate in the market without breaking down, leading to easier removal for the end user. The thinness of this new ostomy seal, together with its composition and design, allows it to absorb up to four times its weight in fluid without breaking down underneath the skin barrier[1]. This high performance, combined with eakin(R) seals' best-in-market moldability[2], makes eakin freeseal(R) a relatable solution to any person living with a stoma immediately post-surgery. Ostomy seals and barriers designed to prevent leakage and skin irritation is one of the largest product categories in the United States and continues to grow at a consistent rate. Dan Yrigoyen, Vice President, US Ostomy Care at Convatec, said: "We are pleased to add eakin freeseal(R) to our ESENTA(TM) family of skin-friendly accessories, expanding the range of trusted options available to clinicians and patients, and supporting easier, more confident everyday care. with our forever caring promise. This marks a new chapter in the longstanding partnership between Convatec and Eakin Healthcare. Together we continue to advance ostomy care in line with our forever caring promise." This co-branded product reflects Convatec and Eakin Healthcare's ongoing commitment to patients and healthcare professionals to provide choice - working together to provide a better ostomy experience so patients can live the life they want. Integrating eakin(R) seals into the ESENTA(TM) range reinforces the importance of using a reliable ostomy seal as part of the customers skincare routine. About Eakin Healthcare Eakin Healthcare is a medical device manufacturer with headquarters based in Comber, Northern Ireland. Founded in 1973, pharmacist Tom Eakin saw a need to support individuals living with a stoma with better ostomy products to improve comfort, confidence, and quality of life. The company continues to build on its heritage of patient-focused innovation, combining clinical insight with advanced manufacturing to deliver reliable medical devices used worldwide. With a global presence and a strong focus on quality, the company works to enhance the lives of people managing complex healthcare needs. To learn more please visit http://www.eakinostomy.com About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com References: * Mc Groggan G, Haughey S and McDowell K (2018) An absorbent, enzyme-inhibiting seal reduces peristomal skin complications. Gastrointestinal Nursing 16:1 42-4. * T.G. Eakin Laboratory Testing Summary report, ostomy seals 2023 (Data on file) EA-005683-ST * Eakin Healthcare Stoma Census 2023 n=1992. Data on file.
ConvaTec Group reported its fifth consecutive year of organic revenue growth in 2025, with operating margin expanding 110 basis points to 22.3% and earnings per share rising 16%. The medical devices company delivered organic growth of 6.4% excluding InnovaMatrix, with strong performance across all four business segments led by infusion care at 12.5%. The company faces a significant headwind from its InnovaMatrix product after US Medicare reduced pricing by approximately 80% to $127 per square centimetre, resulting in a £72 million non-cash impairment and an expected 2% revenue headwind in 2026. Management guided to roughly $20 million in InnovaMatrix sales for 2026. ConvaTec reiterated 2026 guidance for 5-7% organic growth excluding InnovaMatrix and operating margin of at least 23%, whilst raising its longer-term organic growth target to 6-8% from 2027.